Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +1.52% slumped 0.56% to $123.23 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% falling 0.10% to 4,696.05 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% falling 0.47% to 36,236.47. This was the stock's fifth consecutive day of losses. Edwards Lifesciences Corp. closed $8.50 short of its 52-week high ($131.73), which the company reached on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% fell 0.98% to $104.97, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +3.77% fell 1.07% to $42.59, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +2.79% rose 0.27% to $230.59. Trading volume (2.6 M) eclipsed its 50-day average volume of 2.4 M.